Fatigue - Pipeline Review, H2 2018 - ResearchAndMarkets.com

September 25, 2018

DUBLIN--(BUSINESS WIRE)--Sep 25, 2018--The “Fatigue - Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Fatigue - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Fatigue (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Fatigue (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Unknown stages are 3, 1, 2 and 2 respectively.

Fatigue (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

Introduction Report Coverage Fatigue - Overview Fatigue - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Fatigue - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Fatigue - Companies Involved in Therapeutics Development Aoxing Pharmaceutical Company Inc Chronos Therapeutics Ltd K-Pax Pharmaceuticals Inc Merz Pharma GmbH & Co KgaA MultiCell Technologies Inc Resolys Bio Inc For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qgmwwz/fatigue?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925006073/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/25/2018 02:47 PM/DISC: 09/25/2018 02:47 PM


Update hourly